492 results on '"Buchholz TA"'
Search Results
2. Abstract S3-07: Complication and economic burden of local therapy options for early breast cancer
3. Abstract S6-02: Long-term prognostic value of residual cancer burden (RCB) classification following neoadjuvant chemotherapy
4. Abstract P5-14-08: Prospective phase II study of concurrent capecitabine and radiation demonstrates futility in triple negative chemo-resistant breast cancer
5. Abstract P5-14-19: Radiation field design on the ACOSOG Z0011 trial
6. Abstract P5-03-05: Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate metabolic pathway
7. Abstract S2-3: Disparities in the utilization of axillary sentinel lymph node biopsy among black and white patients with node-negative breast cancer from 2002–2007.
8. Abstract PD03-06: Simvastatin radiosensitizes differentiated and stem-like breast cancer cell lines and is associated with improved local control in inflammatory breast cancer patients treated with post-mastectomy radiation
9. Abstract S2-1: The role of sentinel lymph node surgery in patients presenting with node positive breast cancer (T0-T4, N1-2) who receive neoadjuvant chemotherapy – results from the ACOSOG Z1071 trial
10. S2-1: Partial Breast Brachytherapy Is Associated with Inferior Effectiveness and Increased Toxicity Compared with Whole Breast Irradiation in Older Patients.
11. MS4-3: Radiation for Patients Treated with Neoadjuvant Chemotherapy.
12. P1-04-03: The Effect of Survivin Downregulation on Radiosensitization of Breast Cancer Cell Lines Grown under Adherent and Stem Cell Promoting Culture Conditions.
13. Abstract P2-09-02: Validation of a Novel Staging System for Disease-Specific Survival in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy
14. Abstract P1-17-01: Differences in Survival among Women with Stage III Inflammatory and Non-Inflammatory Locally Advanced Breast Cancer Appear Early: A Large Population Based Study
15. Abstract P4-11-15: Outcomes for Breast Cancer Patients with Isolated Metastasis or Recurrence to the Contralateral Nodal Basins
16. Abstract P5-15-03: Patient Characteristics and Clinical Outcome of Patients with Secondary Inflammatory Breast Cancer. M.D. Anderson Cancer Center, Retrospective Review
17. Abstract P4-04-05: Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells
18. Abstract P1-17-02: Outcome after Locoregional Recurrence in Patients with Inflammatory Breast Cancer
19. Immediate versus delayed repair of partial mastectomy defects in breast conservation
20. Novel inflammatory breast cancer cell line, MDA-IBC-1 expresses and secretes WISP3, a putative tumor suppressor in inflammatory breast cancer.
21. Significant increased recurrence rates among breast cancer patients with HER2-positive, T1a,bN0M0 tumors.
22. Populations of cells exhibiting epithelial-mesenchymal transition (EMT) or stem cell characteristics can be propagated from a single inflammatory breast cancer (IBC) cell line based on culture conditions.
23. Breast brachytherapy in the United States: how is this emerging modality being incorporated into the care of older breast cancer patients?.
24. Breast cancer in the United States: the burden on an aging, changing nation.
25. Locally advanced breast cancer frequently involves the extra-axillary regional nodes: incidence and treatment impact.
26. Male breast cancer outcomes: validation and modification of a guideline.
27. Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer.
28. Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early: a large population-based study.
29. Economic burden of renal cell carcinoma in the US: Part II--an updated analysis.
30. Economic burden of renal cell carcinoma: Part I--an updated review.
31. American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer.
32. Prognostic factors of survival in the trastuzumab era among women with breast cancer and brain metastases who receive whole brain radiotherapy: a single-institution review.
33. Racial disparities in the use of radiotherapy after breast-conserving surgery: a national Medicare study.
34. High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
35. Future of cancer incidence in the United States: burdens upon an aging, changing nation.
36. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study.
37. The impact of pregnancy on breast cancer outcomes in women<or=35 years.
38. Triple receptor-negative breast cancer: the effect of race on response to primary systemic treatment and survival outcomes.
39. Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy.
40. Statement of the science concerning locoregional treatments after preoperative chemotherapy for breast cancer: a National Cancer Institute conference.
41. Combined use of clinical and pathologic staging variables to define outcomes for breast cancer patients treated with neoadjuvant therapy.
42. Nuclear factor-kappa B as a predictor of treatment response in breast cancer.
43. Factors predictive of outcome in patients with breast cancer refractory to neoadjuvant chemotherapy.
44. Radiotherapy and survival in breast cancer.
45. Intraoperative radiotherapy for early breast cancer.
46. Should intensity-modulated radiation therapy be the standard of care in the conservatively managed breast cancer patient?
47. [Commentary on] Site of primary tumor has a prognostic role in operable breast cancer: the International Breast Cancer Study Group experience.
48. [Commentary on] Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer.
49. [Commentary on] DCIS of the breast: solving the puzzle.
50. [Commentary on] Thermochemoradiotherapy improves oxygenation in locally advanced breast cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.